An ovarian cancer research trial to evaluate the effectiveness of a new blood test for the early detection of ovarian cancer. AOA Dx has identified a selection of blood markers that have been linked to Ovarian Cancer. By collecting the blood of women with signs and symptoms of ovarian cancer, AOA Dx can evaluate the accuracy of the markers for the early detection of the disease.
Principal Investigator
William P. Irvin Jr, MD
Contact
Riverside Cancer Clinical Team
757-534-6890
[email protected]
Locations
All Peninsula Cancer Institute and Cancer Specialists of Tidewater sites
Status
Recruiting
Category
Oncology
Study #
n/a